SCHEMBL6661573

SCHEMBL6661573

NC(=O)CCN1C=NC=CC1

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.32
MAPK1 P28482 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480879 0.81 KDM4E (0.31) KDM4E
SCHEMBL932028 0.67
SCHEMBL930057 0.66
Hydrochloric Acid SCHEMBL933129 0.66
Hydrochloric Acid SCHEMBL8468845 0.66
SCHEMBL10518267 0.64
SCHEMBL5153124 0.58
SCHEMBL8860545 0.58 L3MBTL1 (0.77) L3MBTL1KDM4EMAPK1SMN1; SMN2
SCHEMBL11598668 0.58 L3MBTL1 (0.77) L3MBTL1KDM4EMAPK1SMN1; SMN2
SCHEMBL1178666 0.58 L3MBTL1 (0.40) L3MBTL1KDM4EMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212327-B8 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2004-02-25 EP disclosed
EP-1212327-A2 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS BASF AKTIENGESELLSCHAFT (DE) 2002-06-12 EP disclosed
WO-2001019829-A2 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS BASF AKTIENGESELLSCHAFT (DE) 2001-03-22 WO disclosed